Our board members, directors and team members serve pro bono and do not charge UG for any out of pocket expenses.
Impact Investment Team
Dan Kukla - New York
Dan performs buyouts and principal investments at The Carlyle Group in New York. Since joining Carlyle in 2011, Dan has been involved in the execution of investments in NGP Energy Capital, Cogentrix, Diversified Global Asset Management and Metropolitan Real Estate. Prior to Carlyle, Dan worked on private equity and M&A mandates at BCG, Lazard, and Schroder Salomon Smith Barney in London, and served in the German military (paratroopers).
Dan was a PhD scholar at Columbia Business School, earned a PhD magna cum laude on private equity at Technical University of Berlin and a Diploma in Business (MBA equivalent) at HHL Leipzig Graduate School of Management, and studied abroad at ESCP Europe in Paris and in the MBA program at Kelley School of Business (DAAD scholarship). Dan ran five marathons, practices martial arts, and plays the piano.
Stephan von Perger - Berlin
Stephan most recently launched Zenjob, a mobile-first staffing marketplace, grew it to six-digit monthly revenues in less than 6 months and raised €1m+ in Venture Capital from top EU and US VCs. Prior to Zenjob, Stephan worked as an early stage investor at Wellington Partners, covering deal flow and portfolio companies across Europe from Wellington's London office.
Prior, he worked for mobile transit startup Citymapper, fashion e-commerce venture Stylistpick as well as McKinsey in London and Dubai. He graduated in Computer Science from Oxford and studied abroad at UC Berkeley and National University of Singapore.
Adam Justin - New York
Adam is a Sr. Associate at Barclay’s Global Healthcare Group. Recent transaction experience includes CRISPR Therapeutics’ $60mm IPO, Abbvie’s $10bn acquisition of Stemcentrx and Vizient’s $2bn acquisition of MedAssets.
Adam earned his BS with Honors at the University of Minnesota and his MBA at Columbia Business School, where Adam was active at Pangea Impact Investing and 118 Capital; with impact investments in Kinvolved and Voz. Today Adam is a member of the Brookings Society New York Chapter and an avid distance runner with six completed marathons (best time sub 3) and other races.
Patryk Radlowski - New York
Pat is an Analyst at Lazard, focusing on M&A advisory. Experience includes the sale of Level 3 Communications to CenturyLink, Blackstone’s sale of its 21% stake in SeaWorld Entertainment and General Communication’s sale to Liberty Ventures. Prior, Patryk was at PineBridge Investments and National Securities.
Pat graduated magna cum laude from New York University, where he earned a BS in Finance and Economics from the Leonard N. Stern School of Business. After completion of his program at Lazard, Pat will join the deal team of Siris Capital, a $3bn AuM tech buyout firm based in New York.
Marcos Blanco, New York / Washington DC
Marcos is the CFO at two startup companies. Prior, Marcos was a VP at SunGard (FIS company), a Partner and CFO at BDMI (Bertelsmann VC fund), worked on M&A opportunities at Random House, was involved with the turnaround of a division of Bayer, worked for Bosch on growing the automotive franchise, and worked on supply chain optimization for Airbus. Marcos earned his MBA at Yale, a law degree from the University of Manchester, and graduated with a dual-degree in International Business Management from the Universities of Hamburg (Germany) and Madrid (Spain). He is fluent in English, Spanish and German.
Salman Khan - New York
Salman is heading Enterprise Client Operations and is part of the management group at Zocdoc, a growth stage digital health company. He is overseeing operations across the Enterprise Implementation team, Customer Success team as well as the Data Operations team.
Prior, Salman was at The Boston Consulting Group as a Principal covering health insurance/hospitals/health systems and at McKinsey covering the pharmaceutical/biotech sector. Salman trained as a physician and also completed a Postdoctoral Fellowship in Cardiac Surgical Transplantation Immunology from Yale University School of Medicine.
Investor & Donor Relations
Steve Simone - Washington DC
Steve is a VP at Carlyle, focused on fundraising for Carlyle’s Global Energy, Natural Resources and Infrastructure Platform, including strategies focused across the energy value chain. Steve was integrally involved in the fundraising for several new strategies incl. International Energy, which raised $2.5bn, Carlyle Power Partners, which raised $2bn+ of commitments.
Prior, Steve worked at Credit Suisse in the Customized Fund Investment Group. He graduated from Hamilton College and studied at Victoria University of Wellington in New Zealand. Steve is an avid hockey fan and enjoys golf and family time with his wife and two children.
Astrid-Caroline Cole - London
Caroline is originally from Germany and studied Diplomacy in Geneva. She is the founder of a well known private art agency in London named ACC Art and represents contemporary artists.
Caroline went to a French boarding school near Paris, wrote her master thesis about the game theoretical implications of the WTO dispute settlement and likes to sail Catamarans in her free time. Caroline is a well known patron to the Tate and the Guggenheim and was voted 'One to Watch' in Vogue Germany.
Günther Laux - Nuremberg
Günther retired after 45 years in the electronics industry, most recently in management positions at Siemens, Europe’s largest manufacturing and electronics company with a mkt cap of ~$100bn. In 2013 he took over the lead for UG Theatre.
With seven other team members, all retirees who actively contribute their time, he transported over 3,000 children into wondrous fairy tales that are performed by the retirees. In addition to weekly rehearsals and regular performances, with a growing demand from nursery-school teachers, the group also writes fairy tales that promote the idea that children and the elderly are good for each other.
In addition to Dr. Dan Kukla and Stephan von Perger, UG's board in Germany includes Dr. Julia Sauerbrey and Dr. Christoph Künne.